Finance

Beta
Lists
AVXL:NASDAQ
Anavex Life Sciences Corp
$2.58
-0.39%
(-0.0100) 1D
$2.58
0.00% (0.00)
After hours
Closed: Jul 1, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AVXL...
Open
$2.59
High
$2.64
Low
$2.56
Mkt. cap
239.09M
Avg. vol.
1.46M
Volume
1.13M
52-wk high
$13.99
52-wk low
$2.41
EPS
-$0.46
Beta
1.20
Shares outstanding
92.67M
No. of employees
34
Open
$2.59
High
$2.64
Low
$2.56
Mkt. cap
239.09M
Avg. vol.
1.46M
Volume
1.13M
52-wk high
$13.99
52-wk low
$2.41
EPS
-$0.46
Beta
1.20
Shares outstanding
92.67M
No. of employees
34
News stories
From sources across the web
About Anavex Life Sciences Corp
CEOChristopher U. Missling Ph.D.
Employees34
Founded2004
HeadquartersNew York, New York, United States
SectorBiotechnology
Websiteanavex.com
Analyst ratings
Based on 1 analyst giving stock ratings to AVXL in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for AVXL in the last 3 months
Highest
Current $2.58
$20.00 (+675.19%)
Average
$20.00 (+675.19%)
Lowest
$20.00 (+675.19%)
Analyst
Recommendation
Action
Price target
Projected
Date
Seema Sheoran
Rodman & Renshaw
Buy
Initiated
$20.00
+675.2%
05/04/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$20.00
+675.2%
03/31/2026
Soumit Roy
JonesTrading
Hold
Maintained
-
-
11/14/2025
Last report
Feb 9, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.06 / -$0.11
+45.45%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
9.80M
9.83M
7.15M
4.62M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.62M
4.50M
3.68M
2.13M
Operating expense
12.42M
14.33M
10.83M
6.75M
Total operating expenses
12.42M
14.33M
10.83M
6.75M
Operating income
-12.42M
-14.33M
-10.83M
-6.75M
Other non operating income
-
25.00K
-
-
EBT including unusual items
-11.20M
-13.24M
-9.83M
-5.66M
EBT excluding unusual items
-11.20M
-13.24M
-9.83M
-5.66M
Income tax expense
-
-
-
18.00K
Effective tax rate
-
-
-
-0.32%
Other operating expenses
-
-
-
-
Net income
-11.20M
-13.24M
-9.83M
-5.68M
Net profit margin
-
-
-
-
Earnings per share
-0.13
-0.16
-0.11
-0.06
Interest and investment income
1.21M
1.08M
999.00K
1.08M
Interest expense
-
-
-
-
Net interest expenses
1.21M
1.08M
999.00K
1.08M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer